XenoPort appoints Dennis Fenton to board
This article was originally published in Scrip
Executive Summary
XenoPort (US) has appointed Dr Dennis Fenton to its board of directors. He has more than 30 years' pharmaceutical and biotechnology industry experience, including 25 years at Amgen.